Cargando…
Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences
OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as subs...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016237/ https://www.ncbi.nlm.nih.gov/pubmed/21104408 http://dx.doi.org/10.1007/s00228-010-0935-x |
_version_ | 1782195698443223040 |
---|---|
author | Toverud, Else-Lydia Røise, Anne Kjersti Hogstad, Grete Wabø, Inger |
author_facet | Toverud, Else-Lydia Røise, Anne Kjersti Hogstad, Grete Wabø, Inger |
author_sort | Toverud, Else-Lydia |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as substituted generic products. Five focus- group discussions were held. RESULTS: Only a few participants claimed to take their medications as prescribed. Most reported low drug adherence before and after generic substitution. Fourteen said that their blood pressure was not under control. Most patients did not know what it meant to get a generic product. They normally accepted what the pharmacy offered, even if they thought the generics were of a lower quality than the brand products. Five participants experienced new side effects. Differences in name, color, form, or taste caused confusion. The patients had been told in the pharmacy that the effect of a generic product was as good as that of the brand product but were still confused, as in most cases the doctor said nothing to them about the substitution. CONCLUSION: Generic substitution works well in Norway as an economic health strategy, but drug adherence remains suboptimal under those circumstances. Patients are insecure with respect to the difference between the old and the new product when it comes to the drug’s physical attributes and perceived quality. Patients would feel safer if the doctor had a more active role in informing them about the system. |
format | Text |
id | pubmed-3016237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30162372011-02-04 Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences Toverud, Else-Lydia Røise, Anne Kjersti Hogstad, Grete Wabø, Inger Eur J Clin Pharmacol Pharmacoeconomics OBJECTIVES: The aim of this study was to investigate experiences with and attitudes toward generic substitution in patients on antihypertensive medication. MATERIALS AND METHODS: Study participants were 22 patients from pharmacies in Oslo who had taken brand antihypertensive products as well as substituted generic products. Five focus- group discussions were held. RESULTS: Only a few participants claimed to take their medications as prescribed. Most reported low drug adherence before and after generic substitution. Fourteen said that their blood pressure was not under control. Most patients did not know what it meant to get a generic product. They normally accepted what the pharmacy offered, even if they thought the generics were of a lower quality than the brand products. Five participants experienced new side effects. Differences in name, color, form, or taste caused confusion. The patients had been told in the pharmacy that the effect of a generic product was as good as that of the brand product but were still confused, as in most cases the doctor said nothing to them about the substitution. CONCLUSION: Generic substitution works well in Norway as an economic health strategy, but drug adherence remains suboptimal under those circumstances. Patients are insecure with respect to the difference between the old and the new product when it comes to the drug’s physical attributes and perceived quality. Patients would feel safer if the doctor had a more active role in informing them about the system. Springer-Verlag 2010-11-23 2011 /pmc/articles/PMC3016237/ /pubmed/21104408 http://dx.doi.org/10.1007/s00228-010-0935-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Pharmacoeconomics Toverud, Else-Lydia Røise, Anne Kjersti Hogstad, Grete Wabø, Inger Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title | Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title_full | Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title_fullStr | Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title_full_unstemmed | Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title_short | Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
title_sort | norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences |
topic | Pharmacoeconomics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016237/ https://www.ncbi.nlm.nih.gov/pubmed/21104408 http://dx.doi.org/10.1007/s00228-010-0935-x |
work_keys_str_mv | AT toverudelselydia norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences AT røiseannekjersti norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences AT hogstadgrete norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences AT wabøinger norwegianpatientsongenericantihypertensivedrugsaqualitativestudyoftheirownexperiences |